Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia

Psychiatry Research: Neuroimaging

Volumn 40, Issue 2, 1991, Pages 115-124

  Bartlett, Elsa J ^a   Wolkin, Adam ^b   Brodie, Jonathan D ^b   Laska, Eugene M ^b   Wolf, Alfred P ^c   Sanfilipo, Michael ^d  

^a NEW YORK UNIVERSITY   (United States)

^b Jonathan D Brodie PhD MD is Professor Department of Psychiatry New York University Medical CenterUSA ^*

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d Adam Wolkin MD is Assistant Professor Department of Psychiatry New York University Medical Center and Staff Psychiatrist Psychiatry Service New York VA Medical CenterUSA ^*

Author keywords

basal ganglia; deoxyglucose; dopamine D2 receptors; frontal lobe; neuroleptics; Positron emission tomography

Indexed keywords

GLUCOSE; HALOPERIDOL; TIOTIXENE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; DRUG RESEARCH; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; BASAL GANGLIA; BLOOD GLUCOSE; BRAIN; BRAIN MAPPING; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; FRONTAL LOBE; HALOPERIDOL; HUMAN; MALE; MIDDLE AGE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; THIOTHIXENE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0026047797     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-4927(91)90003-9     Document Type: Article

References (18)

1. Reproducibility of cerebral glucose metabolic measurements in resting human subjects
2. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients
3. Positron emission tomography in schizophrenic patients with and without neuroleptic medication
4. Regional brain function in schizophrenia: II. Repeated evaluation with positron emission tomography
5. Distribution of effects of haloperidol on energy metabolism in the rat brain
6. Introduction: The Brief Psychiatric Rating Scale: Recent developments in ascertainment and scaling
7. 11F]2-fluoro-2-D-deoxyglucose: Validation of method
8. Reduced metabolic response of the rat brain to haloperidol after chronic treatment
9. Haloperidol and cerebral metabolism in the conscious rat: Relation to pharmacokinetics
10. Glucose metabolic rate kinetic model parameter determination in humans: The lumped constants and rate constants for 18-F-fluorodeoxyglucose and 11-C-deoxyglucose
11. The 18-F-fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man
12. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro
13. Research Diagnostic Criteria: Rationale and reliability
14. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia
15. Sigma receptors: Biology and function
16. Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic-patients as determined by positron emission tomography
17. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography